AngelEye Health Announces Series B Funding to Support Company’s Rapid Growth
Healthcare IT Today
NOVEMBER 14, 2022
Brad Whitmore is a successful investor who has targeted a broad range of investments across various industries with an emphasis on businesses with long-term, sustainable competitive advantages and unique offerings relative to competitors. Within Life Sciences, the firm focuses on MedTech, Diagnostics, and Opportunistic Drug Development.
Let's personalize your content